We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




New System Facilitates Tympanostomy Tube Delivery

By HospiMedica International staff writers
Posted on 12 Dec 2019
An innovative tympanostomy (ear tube) delivery system enables placement of tubes in the comfort of an office environment.

The Tusker Medical (Menlo Park, CA, USA) Tubes Under Local Anesthesia (Tula) system is designed to enable delivery of an ear tube to patients under local anesthesia in a physician's office setting, obviating the need for general anesthesia. More...
The system is composed of four concentric components that cut, dilate, shield, and stabilize. The cutter first creates the myringotomy; the dilator opens the incision, while the shield introduces the tympanostomy tube through the myringotomy. The system is approved for use in both adults and children as young as six months of age.

To facilitate painless delivery, an iontophoresis device is used to deliver a low-level electrical charge to the tympanic membrane in order to accelerate uptake of a local anesthetic (Tymbion) into the ear drum, providing needle-free local anesthesia. The automated tube delivery system then provides single-button insertion of a preloaded Grommet tympanostomy tube through the myringotomy. The cutter is exposed only for the very brief moment (less than 500 milliseconds) when the myringotomy is created, and is otherwise recessed within the device, an important safety feature when performing procedures in an awake child.

“The Tusker Iontophoresis System uses a small amount of electrical current to accelerate the uptake of the local anesthetic into the tympanic membrane,” said Amir Abolfathi, president and CEO of Tusker Medical. “This provides an alternative to phenol (a denaturing acid), ear canal injections, or other local anesthesia methods, none of which have FDA approval for pediatric tympanic membrane anesthesia and are often painful or take an unacceptably long time to achieve anesthesia.”

Otitis media is inflammation of the middle ear that occurs in the area between the tympanic membrane and the inner ear, including a duct known as the eustachian tube. Though painful, otitis media is not threatening and usually heals on its own within 2–6 weeks. In chronic cases with effusions, insertion of a tympanostomy tube into the eardrum reduces recurrence rates in the six months after placement, but has little effect on long term hearing. The tubes are recommended in those who have more than three episodes of acute otitis media in 6 month or 4 in a year associated with an effusion.

Related Links:
Tusker Medical


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
New
Antimicrobial Mat
MULTIMAT
New
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
The intelligent wound dressing consists of a granular hydrogel (Photo courtesy of Apoorv Singh/ETH Zurich)

Intelligent Wound Dressing Reduces Inflammation and Promotes Healing

Chronic wounds, especially those caused by diabetes or circulatory disorders, are a widespread medical problem that burden healthcare systems. Patients often suffer from open skin lesions that fail to... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.